Lataa...
Pazopanib-associated interstitial lung disease in a patient with renal cell carcinoma
Pazopanib is a multi-targeted tyrosine kinase inhibitor, which is indicated for use in patients with advanced renal cell carcinoma or advanced soft-tissue sarcomas. Although rare, interstitial lung disease has been reported as among the adverse sequelae of pazopanib therapy. We report the case of a...
Tallennettuna:
| Julkaisussa: | BMJ Case Rep |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMJ Publishing Group
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7348321/ https://ncbi.nlm.nih.gov/pubmed/32641305 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2020-235177 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|